Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 266227
                    [Title] => Safety of celecoxib affirmed
                    [Summary] => NEW YORK – In response to Merck & Co.’s announcement of the worldwide withdrawal of its COX-2 medicine rofecoxib, Pfizer Inc. issued the following statement:


"Over 27 million patients in the United States have been prescribed with celecoxib, which was approved by the US Food and Drug Administration in 1998. In the Philippines, celecoxib was approved by the Bureau of Food and Drugs in 1999 for the treatment of osteoarthritis and rheumatoid arthritis. It has also been approved for acute pain. 


                    [DatePublished] => 2004-10-14 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

FECZKO

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 266227
                    [Title] => Safety of celecoxib affirmed
                    [Summary] => NEW YORK – In response to Merck & Co.’s announcement of the worldwide withdrawal of its COX-2 medicine rofecoxib, Pfizer Inc. issued the following statement:


"Over 27 million patients in the United States have been prescribed with celecoxib, which was approved by the US Food and Drug Administration in 1998. In the Philippines, celecoxib was approved by the Bureau of Food and Drugs in 1999 for the treatment of osteoarthritis and rheumatoid arthritis. It has also been approved for acute pain. 


                    [DatePublished] => 2004-10-14 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Safety of celecoxib affirmed

October 14, 2004 - 12:00am

NEW YORK – In response to Merck & Co.’s announcement of the worldwide withdrawal of its COX-2 medicine rofecoxib, Pfizer Inc. issued the following statement: "Over 27 million patients in the United...

Science and Environment